Fundraising Fox
/Companies
Sign in

Creative Medical Technology Holdings

NASDAQ: CELZ

Phoenix, US · Nevada corporation

Find your way into Creative Medical Technology Holdings

Sign up to see every warm intro you have to Creative Medical Technology Holdings

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Creative Medical Technology Holdings team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).

BiotechHealthtechMedical Devices

Founders & leadership

TWTimothy Warbington
Timothy WarbingtonFounder · President - CEO
DDDonald Dickerson
Donald DickersonChief Financial Officer, Chief Operating OfficerDonald Dickerson is an executive with experience in operations and finance roles within pharmaceutical and technology companies, with expertise in P&L management, acquisitions, governance, and team leadership.
TI
Thomas IchimNamed on SEC filing

Board

AP
Amit PatelBoard director
AM
Annette MarleauBoard director

Reported raises · per SEC filings

Form D private placements

$22.5M disclosed across 16 of 19 rounds · 1900–2025

▶$17MraisedMay 2022 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald DickersonExecutive Officer, Director
  • Bruce S. UrdangDirector
  • Michael H. FingerDirector
  • Susan SnowDirector
  • Timothy WarbingtonExecutive Officer, Director
Offering amount
$17M
Amount sold
$17M
Sales commissions
$1.4M
Placement agents
Roth Capital Partners
First sale
May 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedAug 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy WarbingtonExecutive Officer, Director
  • Donald DickersonExecutive Officer, Director
  • Amit PatelDirector
  • Thomas IchimDirector
Offering amount
$4.5M
Amount sold
$3.8M
Sales commissions
$312.8K
Placement agents
Roth Capital Partners
First sale
Aug 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$509KraisedSep 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Timothy WarbingtonExecutive Officer, Director
  • Donald DickersonExecutive Officer, Director
  • Amit PatelDirector
Offering amount
$678.7K
Amount sold
$509K
First sale
Sep 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$115KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Amit PatelDirector
  • Timothy WarbingtonExecutive Officer, Director
  • Donald DickersonExecutive Officer, Director
Offering amount
$115K
Amount sold
$115K
Minimum investment
$115K
First sale
Mar 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$27.5KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald DickersonExecutive Officer, Director
  • Amit PatelDirector
  • Timothy WarbingtonExecutive Officer, Director
  • Thomas IchimDirector
Offering amount
$27.5K
Amount sold
$27.5K
Minimum investment
$27.5K
First sale
Feb 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$44KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Amit PatelDirector
  • Donald DickersonExecutive Officer, Director
  • Timothy WarbingtonExecutive Officer, Director
Offering amount
$44K
Amount sold
$44K
Minimum investment
$44K
First sale
Jan 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$48KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy WarbingtonExecutive Officer, Director
  • Amit PatelDirector
  • Thomas IchimDirector
  • Donald DickersonExecutive Officer, Director
Offering amount
$48K
Amount sold
$48K
Minimum investment
$48K
First sale
Mar 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$53KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Donald DickersonExecutive Officer, Director
  • Timothy WarbingtonExecutive Officer, Director
  • Amit PatelDirector
Offering amount
$53K
Amount sold
$53K
Minimum investment
$53K
First sale
Feb 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$26.1Mvaluation at IPODec 2021 · $4.13/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Related companies · 5

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
QuiverquantQuiver Quantitative scrapes and aggregates alternative stock market data from across the internet into a free web dashboard. It targets retail investors, giving non-professional traders access to alternative data typically reserved for institutional money managers.
CordicamedicalCordica Medical provides design, development, and manufacturing services for medical device companies, covering product engineering, precision manufacturing, automated assembly, packaging, and supply chain management through FDA-registered and ISO 13485-certified facilities. It supports programs across therapeutic areas including interventional systems, drug delivery, wound care, and personal health, operating 19 facilities in the United States, Mexico, and Singapore.
CreateCREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
SoFiSoFi Technologies is a digital personal-finance company offering student and personal loans, mortgages, investing, banking and credit cards through one app; it went public on the Nasdaq in 2021 via SPAC.

Companies working in the same space as Creative Medical Technology Holdings.

Frequently asked questions

What does Creative Medical Technology Holdings do?
Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).
Who founded Creative Medical Technology Holdings?
Creative Medical Technology Holdings was founded by Timothy Warbington.
How much funding has Creative Medical Technology Holdings raised?
Creative Medical Technology Holdings has disclosed $22.5M raised across 16 of its 19 known rounds.
Where is Creative Medical Technology Holdings headquartered?
Creative Medical Technology Holdings is headquartered in Phoenix, US.